Request Sample
Request Methodology
Description
Global wearable insulin devices market was valued at US$ 17 Bn in 2020 and expected to grow at 8.9% Compound Annual Growth Rate (CAGR) from 2021 to 2027. Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia. Over the projection period, widespread availability of wearable insulin devices market such as insulin pens, syringes, pumps, and jet injectors will additionally boost demand for insulin delivery devices. Increased public awareness initiatives and campaigns regarding diabetes and its complications, long-term consequences, and treatment will drive demand for insulin-delivery devices. Obesity and diabetes are on the rise all over the world, which is fueling the market for insulin delivery devices. More significant aspects projected to have a positive impact on market growth include technological advancements in these devices, as well as increased patient knowledge regarding diabetes management. Insulin jet injections have no needles, whereas insulin pumps are comfortable to wear. Each device type has its own set of characteristics, but insulin pumps are expected to be a substantial income generator for the market. In the coming years, the market for insulin pumps will be propelled by the launch of enhanced insulin delivery systems, such as portable insulin pumps.
